Pipeline Review on Lung Transplantation Therapeutic Industry, H1 2014

About This Presentation
Title:

Pipeline Review on Lung Transplantation Therapeutic Industry, H1 2014

Description:

“Lung Transplantation - Pipeline Review, H1 2014” report provides a review of the products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. – PowerPoint PPT presentation

Number of Views:79

less

Transcript and Presenter's Notes

Title: Pipeline Review on Lung Transplantation Therapeutic Industry, H1 2014


1
Lung Transplantation - Pipeline Review, H1 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
  • Published January 2014
  • Single User PDF US 2000
  • Corporate User PDF US 6000

2
Lung Transplantation - Pipeline Review,
H1 2014
  • Lung Transplantation - Pipeline Review, H1
    2014'', provides an overview of the indications
    therapeutic pipeline. This report provides
    information on the therapeutic development for
    Lung Transplantation, complete with latest
    updates, and special features on late-stage and
    discontinued projects. It also reviews key
    players involved in the therapeutic development
    for Lung Transplantation. Lung Transplantation-
    Pipeline Review, Half Year is built using data
    and information sourced from databases,
    Company/University websites, SEC filings,
    investor presentations and featured press
    releases from company/university sites and
    industry-specific third party sources, put
    together by research team.
  • Scope
  • A snapshot of the global therapeutic scenario for
    Lung Transplantation.
  • A review of the Lung Transplantation products
    under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources.
  • Coverage of products based on various stages of
    development ranging from discovery till
    registration stages.
  • A feature on pipeline projects on the basis of
    monotherapy and combined therapeutics.
  • Inquiry Before Buying on this Report _at_
    http//www.reportsnreports.com/contacts/InquiryBef
    oreBuy.aspx?name274908.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Lung Transplantation - Pipeline Review,
H1 2014
  • Coverage of the Lung Transplantation pipeline on
    the basis of route of administration and molecule
    type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
  • Reasons to buy
  • Identify and understand important and diverse
    types of therapeutics under development for Lung
    Transplantation.
  • Identify emerging players with potentially strong
    product portfolio and design effective
    counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by
    identifying players of the most promising
    pipeline.
  • Devise corrective measures for pipeline projects
    by understanding Lung Transplantation pipeline
    depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope.
  • Modify the therapeutic portfolio by identifying
    discontinued projects and understanding the
    factors that drove them from pipeline.
  • Inquire for Discount _at_ http//www.reportsnreports.
    com/contacts/Discount.aspx?name274908

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Lung Transplantation - Pipeline Review,
H1 2014
  • List of Tables
  • Number of Products under Development for Lung
    Transplantation, H1 2014 7
  • Number of Products under Development for Lung
    Transplantation - Comparative Analysis, H1 2014 8
  • Number of Products under Development by
    Companies, H1 2014 9
  • Comparative Analysis by Late Stage Development,
    H1 2014 10
  • Comparative Analysis by Early Stage Development,
    H1 2014 11
  • Lung Transplantation - Pipeline by Quark
    Pharmaceuticals, Inc., H1 2014 12
  • Lung Transplantation - Pipeline by Vectura Group
    plc, H1 2014 13
  • Lung Transplantation - Pipeline by Proteo, Inc.,
    H1 2014 14
  • Lung Transplantation - Pipeline by APT
    Pharmaceuticals, Inc. (Inactive), H1 2014 15
  • Lung Transplantation - Pipeline by Neopharm Ltd.,
    H1 2014 16
  • Assessment by Monotherapy Products, H1 2014 17
  • Number of Products by Stage and Target, H1 2014
    19
  • Number of Products by Stage and Mechanism of
    Action, H1 2014 21
  • Number of Products by Stage and Route of
    Administration, H1 2014 23
  • Number of Products by Stage and Molecule Type, H1
    2014 25

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Lung Transplantation - Pipeline Review,
H1 2014
  • Number of Products by Stage and Therapeutic
    Class, H1 2014 27
  • Lung Transplantation Therapeutics - Recent
    Pipeline Updates, H1 2014 36
  • List of Figures
  • Number of Products under Development for Lung
    Transplantation, H1 2014 7
  • Number of Products under Development for Lung
    Transplantation - Comparative Analysis, H1 2014 8
  • Number of Products under Development by
    Companies, H1 2014 9
  • Assessment by Monotherapy Products, H1 2014 17
  • Number of Products by Top 10 Target, H1 2014 18
  • Number of Products by Stage and Top 10 Target, H1
    2014 19
  • Number of Products by Top 10 Mechanism of Action,
    H1 2014 20
  • Number of Products by Stage and Top 10 Mechanism
    of Action, H1 2014 21
  • Number of Products by Top 10 Route of
    Administration, H1 2014 22
  • Number of Products by Stage and Top 10 Route of
    Administration, H1 2014 23
  • Number of Products by Top 10 Molecule Type, H1
    2014 24

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Lung Transplantation - Pipeline Review, H1
2014
  • Number of Products by Top 10 Route of
    Administration, H1 2014 23
  • Number of Products by Stage and Top 10 Route of
    Administration, H1 2014 24
  • Number of Products by Top 10 Molecule Type, H1
    2014 25
  • Number of Products by Stage and Top 10 Molecule
    Type, H1 2014 26
  • Number of Products by Top 10 Therapeutic Class,
    H1 2014 27
  • Number of Products by Stage and Top 10
    Therapeutic Class, H1 2014 28
  • Complete report of 44 Pages is available _at_
    http//www.reportsnreports.com/reports/274908-lung
    -transplantation-pipeline-review-h1-2014.html

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
Write a Comment
User Comments (0)